Eagle Pharmaceuticals
EGRX
#9801
Rank
โ‚ฌ9.21 M
Marketcap
0,71ย โ‚ฌ
Share price
-11.76%
Change (1 day)
-91.99%
Change (1 year)

Revenue for Eagle Pharmaceuticals (EGRX)

Revenue in 2023 (TTM): โ‚ฌ0.24 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.24 Billion. In 2022 the company made a revenue of โ‚ฌ0.29 Billion an increase over the revenue in the year 2021 that were of โ‚ฌ0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eagle Pharmaceuticals from 2013 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚ฌ0.24 B-17.36%
2022 โ‚ฌ0.29 B94.86%
2021 โ‚ฌ0.15 B-0.79%
2020 โ‚ฌ0.15 B-12.68%
2019 โ‚ฌ0.17 B-6.22%
2018 โ‚ฌ0.18 B-5.48%
2017 โ‚ฌ0.19 B9.51%
2016 โ‚ฌ0.18 B197.41%
2015 โ‚ฌ60.57 M283.53%
2014 โ‚ฌ15.79 M23.31%
2013 โ‚ฌ12.8 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ83.13 B 33,949.96%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.15 B 15,529.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ47.34 B 19,290.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ15.44 B 6,224.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ30.84 B 12,532.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.73 B 15,766.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ44.96 B 18,317.71%๐Ÿ‡บ๐Ÿ‡ธ USA